Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

Conditions: Head and Neck Cancer; Recurrent Cancer Interventions: Drug: Penicillamine Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting

https://clinicaltrials.gov/study/NCT06103617

Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials

More News: Cancer | Cancer & Oncology | Head and Neck Cancer | Hospitals | Research